Literature DB >> 10925700

A combination of genetic suppressor elements produces resistance to drugs inhibiting DNA replication.

V V Levenson1, E Lausch, D J Kirschling, E V Broude, I A Davidovich, S Libants, V Fedosova, I B Roninson.   

Abstract

Many anticancer drugs inhibit DNA replication. To investigate the mechanism of permanent growth inhibition after transient arrest of DNA replication, we selected genetic suppressor elements (GSEs) conferring resistance to replication inhibitor Aphidicolin. Starting from a retroviral expression library carrying normalized fragments of human cell cDNA, we isolated four GSEs which, when introduced as a combination, produced resistance to Aphidicolin, doxorubicin and hydroxyurea in HT1080 fibrosarcoma cells. The four GSEs were derived from ORFX bromodomain protein gene, WIZ zinc finger protein gene, the gene for subunit 3 of cytochrome c oxidase, and the gene corresponding to an EST with no known function. A cell line carrying all four GSEs showed a weaker induction of the senescence-like phenotype after treatment with Aphidicolin or doxorubicin; the resistance of this cell line was not associated with decreased doxorubicin accumulation. These results indicate that combined effects of GSEs derived from these four genes increase cellular resistance to replication-inhibiting drugs, possibly by inhibiting drug-induced senescence.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10925700     DOI: 10.1023/b:scam.0000007136.49230.b3

Source DB:  PubMed          Journal:  Somat Cell Mol Genet        ISSN: 0740-7750


  7 in total

1.  Genetic selection for modulators of a retinoic-acid-responsive reporter in human cells.

Authors:  Burt Richards; Jon Karpilow; Christine Dunn; Isaac Peterson; Andrew Maxfield; Ludmilla Zharkikh; Majid Abedi; Anthony Hurlburt; Joshua Hardman; Forrest Hsu; Wenhua Li; Matthew Rebentisch; Robert Sandrock; Tanya Sandrock; Alexander Kamb; David H-F Teng
Journal:  Genetics       Date:  2003-03       Impact factor: 4.562

2.  Arkadia, a novel SUMO-targeted ubiquitin ligase involved in PML degradation.

Authors:  Yigit Erker; Helene Neyret-Kahn; Jacob S Seeler; Anne Dejean; Azeddine Atfi; Laurence Levy
Journal:  Mol Cell Biol       Date:  2013-03-25       Impact factor: 4.272

3.  A proteomic characterization of factors enriched at nascent DNA molecules.

Authors:  Andres J Lopez-Contreras; Isabel Ruppen; Maria Nieto-Soler; Matilde Murga; Sara Rodriguez-Acebes; Silvia Remeseiro; Sara Rodrigo-Perez; Ana M Rojas; Juan Mendez; Javier Muñoz; Oscar Fernandez-Capetillo
Journal:  Cell Rep       Date:  2013-03-28       Impact factor: 9.423

4.  A screen for genetic suppressor elements of hepatitis C virus identifies a supercharged protein inhibitor of viral replication.

Authors:  Rudo L Simeon; Zhilei Chen
Journal:  PLoS One       Date:  2013-12-31       Impact factor: 3.240

5.  Nociceptin/orphanin FQ opioid receptor (NOP) selective ligand MCOPPB links anxiolytic and senolytic effects.

Authors:  Marco Raffaele; Kristina Kovacovicova; Tommaso Biagini; Oriana Lo Re; Jan Frohlich; Sebastiano Giallongo; James D Nhan; Antonino Giulio Giannone; Daniela Cabibi; Martin Ivanov; Anton B Tonchev; Martin Mistrik; Matthew Lacey; Petr Dzubak; Sona Gurska; Marian Hajduch; Jiri Bartek; Tommaso Mazza; Vincenzo Micale; Sean P Curran; Manlio Vinciguerra
Journal:  Geroscience       Date:  2021-11-24       Impact factor: 7.713

6.  Chromosomal localization of cohesin is differentially regulated by WIZ, WAPL, and G9a.

Authors:  Megan Justice; Audra F Bryan; Juanita C Limas; Jeanette Gowen Cook; Jill M Dowen
Journal:  BMC Genomics       Date:  2022-04-30       Impact factor: 3.969

7.  A functional selection of viral genetic elements in cultured cells to identify hepatitis C virus RNA translation inhibitors.

Authors:  Loic Jaffrelo; Sandrine Chabas; Sandrine Reigadas; Aude Pflieger; Czeslaw Wychowski; Julie Rumi; Michel Ventura; Jean-Jacques Toulmé; Cathy Staedel
Journal:  Nucleic Acids Res       Date:  2008-07-09       Impact factor: 16.971

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.